News from the FDA/CDC

Children and COVID: A look back as the fourth year begins


 

Since Omicron

There has not been another major COVID-19 surge since the winter of 2021-2022, when the weekly rate of new cases reached 1,900 per 100,000 population in children aged 16-17 years in early January 2022 – the highest seen among children of any of the CDC’s age groups (0-4, 5-11, 12-15, 16-17) during the entire pandemic. Since the Omicron surge, the highest weekly rate was 221 per 100,000 during the week of May 15-21, again in 16- to 17-year-olds, the CDC reports.

The widely anticipated surge of COVID in the fall and winter of 2022 and 2023 – the so-called “tripledemic” involving influenza and respiratory syncytial virus – did not occur, possibly because so many Americans were vaccinated or previously infected, experts suggested. New-case rates, emergency room visits, and hospitalizations in children have continued to drop as winter comes to a close, CDC data show.

Pages

Recommended Reading

COVID infection provides immunity equal to vaccination: Study
Journal of Clinical Outcomes Management
Pfizer COVID vaccine effective in young children, study shows
Journal of Clinical Outcomes Management
COVID vs. flu: Which is deadlier?
Journal of Clinical Outcomes Management
Prone positioning curbs need for intubation in nonintubated COVID-19 patients
Journal of Clinical Outcomes Management
Celiac disease appears to double COVID-19 hospitalization risk
Journal of Clinical Outcomes Management
Even mild COVID is hard on the brain
Journal of Clinical Outcomes Management
One in four parents lied about kids’ COVID status: Survey
Journal of Clinical Outcomes Management
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
Journal of Clinical Outcomes Management
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
Journal of Clinical Outcomes Management
Factors linked with increased VTE risk in COVID outpatients
Journal of Clinical Outcomes Management